Is tubeless percutaneous nephrolithotomy really less injurious than standard in the midterm?
Although tubeless PCNL was successful and was associated with a shorter hospital stay and less kidney damage in the short-term period compared with standard PCNL, both procedures may cause an almost equal degree of damage in the midterm.
These studies demonstrate that mHGF markedly improves islet transplant outcomes in the highest preclinical species examined to date. HGF has promise as an agent that can improve islet mass and function in transplant models and likely in other models of types 1 and 2 diabetes.